Euclidean Capital’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Sell |
|
|||||
|
2025
Q1 | $803K | Hold |
|
|||||
|
2024
Q4 | $1.04M | Hold |
|
|||||
|
2024
Q3 | $1.32M | Hold |
|
|||||
|
2024
Q2 | $2.01M | Hold |
|
|||||
|
2024
Q1 | $5.91M | Hold |
|
|||||
|
2023
Q4 | $16.3M | Hold |
|
|||||
|
2023
Q3 | $10.9M | Buy |
|
|||||
|
2023
Q2 | $10.7M | Buy |
|
|||||
|
2023
Q1 | $7.94M | Hold |
|
|||||
|
2022
Q4 | $8.57M | Hold |
|
|||||
|
2022
Q3 | $10.4M | Hold |
|
|||||
|
2022
Q2 | $7.9M | Hold |
|
|||||
|
2022
Q1 | $9.52M | Hold |
|
|||||
|
2021
Q4 | $15.9M | Sell |
|
|||||
|
2021
Q3 | $19.7M | Sell |
|
|||||
|
2021
Q2 | $23.4M | Hold |
|
|||||
|
2021
Q1 | $16.3M | Hold |
|
|||||
|
2020
Q4 | $14.5M | Buy |
|